The Scientist

» clinical trials

Most Recent

image: The Sounds of Silence

The Sounds of Silence

By | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.

3 Comments

image: Novartis Buys Rights to GSK MS Drug for $1 Billion

Novartis Buys Rights to GSK MS Drug for $1 Billion

By | August 24, 2015

The multiple sclerosis treatment has yet to be tested in Phase 3 clinical trials.

0 Comments

image: #IceBucketChallenge Payoff

#IceBucketChallenge Payoff

By | August 20, 2015

A year after the viral ALS awareness campaign raised millions, researchers say they have something to show for the influx of funds.

0 Comments

image: Ebola Vax Success

Ebola Vax Success

By | August 3, 2015

An experimental vaccine against Ebola virus disease may completely protect people against infection, according to a clinical study in Guinea.

0 Comments

image: Why an HIV Vax Only Works for Some

Why an HIV Vax Only Works for Some

By | July 15, 2015

Scientists identify a human leukocyte antigen gene linked to immune protection from HIV following vaccination.

1 Comment

image: More Transparency in IRB-Industry Ties

More Transparency in IRB-Industry Ties

By | July 13, 2015

Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.

0 Comments

image: CF Gene Therapy Shows Promise

CF Gene Therapy Shows Promise

By | July 6, 2015

The results of a Phase 2 trial suggest that delivering normal copies of the gene that causes cystic fibrosis may slow lung decline.

0 Comments

image: Breaking Down Barriers

Breaking Down Barriers

By | July 1, 2015

Finding and recruiting diverse populations for clinical studies

0 Comments

image: Celladon Shutters Its R&D

Celladon Shutters Its R&D

By | June 26, 2015

Biotech firm likely to pull the plug after its gene therapy product fails.

0 Comments

image: Device Trials Go Unpublished

Device Trials Go Unpublished

By | June 24, 2015

Just half of the clinical studies used to gain premarket approval for cardiac devices ever make it into the scientific literature.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS